Instituto Oncologico Bureau (IOB)
Madrid 28034
0 studies enrolling now ยท 1 studies all time
What they study most
Metastatic Breast Cancer
Studies at this site
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
โ Completed